42087 Safety of Berdazimer Gel 10.3% in the Treatment of Molluscum Contagiosum: Integrated Results from the B-SIMPLE Phase 3 Program

Background: Berdazimer gel 10.3% is a topical nitric oxide releasing medication in Phase 3 development for the treatment of molluscum contagiosum. Objective: To assess the safety of berdazimer gel 10.3% in three phase 3 molluscum studies B-SIMPLE 1, 2 and 4 (NCTs: 03927716, 03927703, 04535531).